These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 10901376)
1. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376 [TBL] [Abstract][Full Text] [Related]
2. Influence of tumour size on uptake of(111)ln-DTPA-labelled pegylated liposomes in a human tumour xenograft model. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Abra RM; Uster PS; Peters AM; Stewart JS Br J Cancer; 2000 Sep; 83(5):684-8. PubMed ID: 10944612 [TBL] [Abstract][Full Text] [Related]
3. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971 [TBL] [Abstract][Full Text] [Related]
5. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Harrington KJ; Mohammadtaghi S; Uster PS; Glass D; Peters AM; Vile RG; Stewart JS Clin Cancer Res; 2001 Feb; 7(2):243-54. PubMed ID: 11234875 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution and pharmacokinetics of 111In-dTPA-labelled pegylated liposomes after intraperitoneal injection. Syrigos KN; Vile RG; Peters AM; Harrington KJ Acta Oncol; 2003; 42(2):147-53. PubMed ID: 12801133 [TBL] [Abstract][Full Text] [Related]
7. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Chen P; Cameron R; Wang J; Vallis KA; Reilly RM J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194 [TBL] [Abstract][Full Text] [Related]
11. Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model. Harrington KJ; Rowlinson-Busza G; Uster PS; Vile RG; Peters AM; Stewart JS Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1141-8. PubMed ID: 11240257 [TBL] [Abstract][Full Text] [Related]
12. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives. Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330 [TBL] [Abstract][Full Text] [Related]
13. Doubly radiolabeled liposomes for pretargeted radioimmunotherapy. Mougin-Degraef M; Bourdeau C; Jestin E; Saï-Maurel C; Bourgeois M; Saëc PR; Thédrez P; Gestin JF; Barbet J; Faivre-Chauvet A Int J Pharm; 2007 Nov; 344(1-2):110-7. PubMed ID: 17592745 [TBL] [Abstract][Full Text] [Related]
14. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals. Helbok A; Decristoforo C; Dobrozemsky G; Rangger C; Diederen E; Stark B; Prassl R; von Guggenberg E J Liposome Res; 2010 Sep; 20(3):219-27. PubMed ID: 19863193 [TBL] [Abstract][Full Text] [Related]
15. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan. Hao YL; Deng YJ; Chen Y; Wang KZ; Hao AJ; Zhang Y J Pharm Pharmacol; 2005 Oct; 57(10):1279-87. PubMed ID: 16259756 [TBL] [Abstract][Full Text] [Related]
16. The effect of irradiation on the biodistribution of radiolabeled pegylated liposomes. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Peters AM; Stewart JS Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):809-20. PubMed ID: 11395251 [TBL] [Abstract][Full Text] [Related]
17. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160 [TBL] [Abstract][Full Text] [Related]
18. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Vile RG; Uster PS; Peters AM; Stewart JS Clin Cancer Res; 2000 Dec; 6(12):4939-49. PubMed ID: 11156255 [TBL] [Abstract][Full Text] [Related]
19. The effect of chelating agents on the distribution of monoclonal antibodies in mice. Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701 [TBL] [Abstract][Full Text] [Related]
20. Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model. Wang SX; Bao A; Phillips WT; Goins B; Herrera SJ; Santoyo C; Miller FR; Otto RA Int J Pharm; 2009 May; 373(1-2):156-64. PubMed ID: 19429301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]